Although latex agglutination assays for detection of a variety of bacterial antigens in body fluids from patients with systemic infection have been shown to be useful as rapid diagnostic techniques, lack of commercial availability has restricted their application. The Streptex latex test kit for the detection of group B streptococcal (GBS) antigen in admission body fluid specimens was evaluated for sensitivity and specificity in 54 infants with meningitis and in 10 infants with normal cerebrospinal fluid (CSF) parameters. GBS antigen was detected in 22 of 28 (78.6%) CSF specimens by latex agglutination and in 23 It is well documented that latex particle agglutination (LPA) is a sensitive and specific method for the detection of a variety of bacterial antigens in body fluids from patients with systemic infection, particularly meningitis (2, (4) (5) (6) . Compared with countercurrent immunoelectrophoresis (CIE), a more widely used technique, LPA requires no special equipment or trained personnel for its performance, and, in most instances, it is more sensitive than CIE for the detection of soluble polysaccharide antigens in body fluids (3, 7) . However, one disadvantage of agglutination assays has been their limited availability.
Recently, a commercial latex test kit has been developed for the serological differentiation of group A, B, C, D, F, and G streptococci from broth and solid culture media. Since the group B Streptococcus is the most common pathogen associated with meningitis occurring during the first 2 months of life in our hospitals, this study was designed to evaluate the usefulness of the Streptex latex kit in detecting group B streptococcal (GBS) antigen in body fluid specimens from infants in this age group.
MATERIALS AND METHODS
Admission cerebrospinal fluid (CSF) specimens were collected from 67 infants and centrifuged, and the supernatants were stored at 4°C until testing. Among these 67 patients, the following diagnoses were noted: culture-proven bacterial meningitis (43 patients), aseptic meningitis (11 patients), GBS bacteremia without meningitis (3 patients), and normal CSF (10 patients). Fifteen of the 28 patients with GBS meningitis had admission serum and urine specimens collected for testing in addition to CSF. Urine was concentrated 25 to 50 times in a Minicon B15 concentrator (Amicon Corp., Lexington, Mass.). Twenty-six CSF specimens obtained after the initiation of antimicrobial therapy in 15 patients with GBS meningitis were also available for testing.
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